Course Overview

Turner Talks with Cheryl Turner: Guests Dr. Richard Fleming and Jordan Johnson Discuss Big Pharma and Government in Healthcare (CE ARRT)

CE ARRTOnline Video*Imaging, **Self-Study/On-Demand
  • Course Credit Type:CE ARRT
  • Course Category:*Imaging, **Self-Study/On-Demand
  • Course Format:Online Video
  • Course Credit:1.00
  • Course Cost:Free | Included in All-Access Pass
  • Faculty:Cheryl S. Turner, EdD., R.T., (R)(T)
  • Course Release Date:March 24, 2020
  • Course Expiration Date:March 24, 2021
  • Mobile Friendly:Yes
  • Course Producer:AltusLearn
  • Rewards Points Earned:25
course image
You need to  log in  or  create a user account  before you can enroll.

Program Summary

What is the role of Big Pharma on the costs of healthcare? On this Turner Talk, we talk with Dr. Richard Fleming and Jordan Johnson about emerging technologies and new treatment options. How are new pharmaceuticals developed and who makes the decisions about patient accessibility to innovative drugs? Insurance and government entities have a responsibility in research and development of…

What is the role of Big Pharma on the costs of healthcare? On this Turner Talk, we talk with Dr. Richard Fleming and Jordan Johnson about emerging technologies and new treatment options. How are new pharmaceuticals developed and who makes the decisions about patient accessibility to innovative drugs? Insurance and government entities have a responsibility in research and development of new drugs and treatment protocols. Ultimately, we will discuss the price of life. Do higher priced drugs lead to greater, more effective treatments and outcomes? Listen to this exciting and informative episode to really challenge your ideas about treatment costs and the effects on patients.


Upon completion of this course, you will be able to:
  1. Describe new and emerging pharmaceuticals used in diagnosis and treatment
  2. Understand the impact of high cost drugs on patient accessibility
  3. Discuss the importance of research and development for new treatment options
  4. Understand the role of key decision makers for new treatment options